In vivo bypass of hemophila A coagulation defect by Factor XIIa implant
Article Abstract:
Administration of recombinant Factor VIIa and Factor IX can overcome the coagulation defects associated with Hemophilia A and B respectively. Researchers have developed a continuous regeneration of Factor VIIa, which had formerly exhibited too short a half-life for clinical use.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Production of hepatitis B surface antigen in transgenic plants for oral immunization
Article Abstract:
The article presents data showing oral immunogenicity of recombinant hepatitis B surface antigen (HBsAg) in preclinical animal trials.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
In vitro selection of necleoprotein enzymes
Article Abstract:
Nucleic acids selected in vitro can catalyze a broad range of reactions even in the absence of proteins.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Effects in live cells of a c-myc anti-gene PNA linked to a nuclear localization signal. Alteration of Cre recombinase site specificity by substrate-linked protein evolution
- Abstracts: A decade of corporate women: some progress in the boardroom, none in the executive suite. International experience in the executive suite: the path to prosperity?
- Abstracts: Identification of in vivo DNA targets of chromatin proteins using tethered Dam methyltransferase. Aptamers on the scaffold
- Abstracts: Analyzing proteome topology and function by automated multidimensional fluorescence microscopy. Structural genomics and its importance for gene function analysis